ICAD
ICAD Inc
Price:  
1.82 
USD
Volume:  
115,854.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-187.0%
Upside

As of 2024-11-03, the EV/EBITDA ratio of ICAD Inc (ICAD) is -6.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 27.95 mil USD. ICAD's TTM EBITDA according to its financial statements is -4.61 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.3x - 17.7x 10.9x
Forward P/E multiples 9.7x - 22.5x 16.2x
Fair Price (0.91) - (2.30) (1.58)
Upside -150.0% - -226.6% -187.0%
1.82 USD
Stock Price
(1.58) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-21 -6.07
2024-10-18 -6.47
2024-10-17 -6.82
2024-10-16 -6.82
2024-10-15 -4.74
2024-10-14 -4.40
2024-10-11 -3.99
2024-10-10 -3.59
2024-10-09 -3.94
2024-10-08 -4.37
2024-10-07 -4.57
2024-10-04 -4.57
2024-10-03 -4.40
2024-10-02 -4.86
2024-10-01 -4.40
2024-09-30 -4.60
2024-09-27 -5.15
2024-09-26 -4.89
2024-09-25 -4.51
2024-09-24 -4.54
2024-09-23 -4.63
2024-09-20 -4.69
2024-09-19 -4.57
2024-09-18 -4.97
2024-09-17 -5.09
2024-09-16 -4.86
2024-09-13 -5.03
2024-09-12 -4.34
2024-09-11 -3.59
2024-09-10 -3.59
2024-09-09 -3.62
2024-09-06 -3.76
2024-09-05 -4.28
2024-09-04 -4.28
2024-09-03 -4.40
2024-08-30 -4.86
2024-08-29 -4.57
2024-08-28 -4.51
2024-08-27 -4.63
2024-08-26 -4.80
2024-08-23 -5.38
2024-08-22 -5.44
2024-08-21 -5.38
2024-08-20 -5.03
2024-08-19 -5.61
2024-08-16 -5.26
2024-08-15 -4.17
2024-08-14 -3.65
2024-08-13 -3.42
2024-08-12 -3.30